P155 Arsenic trioxide (ATO) and gemtuzumab ozogamicin (GO) in high-risk MDS or AML arising from MDS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • Sekeres, MA; Kalaycio, ME; Erba, HP; Sobecks, R; Advani, A; Chan, J; Maciejewski, JP

Published Date

  • May 2007

Published In

Volume / Issue

  • 31 /

Start / End Page

  • S125 - S125

Published By

International Standard Serial Number (ISSN)

  • 0145-2126

Digital Object Identifier (DOI)

  • 10.1016/s0145-2126(07)70225-4